BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ciprofibrate
,
rs3825942
,
FXYD4
,
Response to oxidative stress
,
Breast Cancer
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MerTK
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Microglial cell
Plasma cell of spleen
Adrenal gland cortex
Myeloid cells of peripheral blood
Adrenal gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
The Synthesis and Initial Evaluation of MerTK Targeted PET Agents.
Structure and functions of Mer, an innate immune checkpoint.
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease.
MERTK missense variants in three patients with retinitis pigmentosa.
HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease
Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gen…
Mer-TK in Human Cardiac Cells
Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Par…
Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carc…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ